The Inflation Reduction Act: A Big Issue for Small-Molecule Medicine
Runaway inflation and economic instability is terrible for just about everybody, but are efforts to tackle this problem creating more?
To answer that, Kirsten Axelsen, Senior Policy Advisor at DLA Piper, joins the show to break down all the effects The Inflation Reduction act is having upon medicine,
We discuss:
The potential negative impacts on small-molecule medicine
How the act affects patents and generic medicine
Why we may see declines in small-molecule medicine research
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.